Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544202 | SCV000630108 | pathogenic | Progressive sclerosing poliodystrophy | 2023-12-25 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 579 of the POLG protein (p.Arg579Trp). This variant is present in population databases (rs556925652, gnomAD 0.01%). This missense change has been observed in individuals with autosomal recessive POLG-related conditions (PMID: 12975295, 33486010). ClinVar contains an entry for this variant (Variation ID: 458695). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt POLG protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001584248 | SCV001812319 | likely pathogenic | not provided | 2023-02-23 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12975295, Alghtani_Article, 33486010) |
Athena Diagnostics | RCV001584248 | SCV001879829 | uncertain significance | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001584248 | SCV004137637 | uncertain significance | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | POLG: PM2 |
Baylor Genetics | RCV000544202 | SCV005056571 | likely pathogenic | Progressive sclerosing poliodystrophy | 2024-02-28 | criteria provided, single submitter | clinical testing |